[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-406495-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-406495-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","quality-of-life-beyond-measure-advanced-cancer-patients-wellbeing-and-medicinal-cannabis","Quality of life beyond measure - Advanced cancer patients, wellbeing and medicinal cannabis","","Advanced cancer experiences are reassembled around illness, symptoms, and the pursuit of “wellbeing,” while medical cannabis is framed at a social threshold between stigma and normalisation, and between recreational and pharmaceutical use. In hyper-medicalised RCT contexts, cancer, wellbeing, and cannabis benefits are often reduced to individualised numerical quality-of-life scores. This article foregrounds patients’ perceptions through a sociological sub-study, using a Deleuzo–Guattarian lens to show embodied fragmentation and relational affect.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/quality-of-life-beyond-measure-advanced-cancer-patients-wellbeing-and-medicinal-cannabis/406495/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/quality-of-life-beyond-measure-advanced-cancer-patients-wellbeing-and-medicinal-cannabis/406495.png","ImageObject",300,407,{"name":42,"@type":43},"pop out","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-28",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does the article critique conventional quality-of-life measurement in advanced cancer trials?","Question",{"text":63,"@type":64},"It argues that in RCT settings, quality of life, wellbeing, and medical cannabis benefits are narrowly assessed through individualistic numerical scores, which limits how patients’ lived experiences are captured.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What social boundaries does the article highlight for medicinal cannabis?",{"text":68,"@type":64},"It situates medical cannabis at a borderline between stigmatised and normalised use, and between recreational and pharmaceutical frames, linking discourse, experience, and perceived scientific proof of benefit.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the study explore wellbeing among advanced cancer patients?",{"text":72,"@type":64},"It presents novel findings from a sociological sub-study embedded within RCTs, focusing on patients’ perceptions and embodied, relational experiences of wellbeing, including how desire and body reassembly shape what wellbeing means.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},406495,1790759939,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":4},962090760408,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","DOI: 10. 1111/1467-9566 .13684  \nORIGINAL ARTICLE  \nQuality of life beyond measure: Advanced cancer patients, wellbeing and medicinal cannabis  \nAlexandra Smith1  | Rebecca E. Olson1  | Nathalia Cordeiro da Costa2,3 | Maddison Cuerton1 | Janet Hardy4 | Philip Good4,5  \n1School of Social Science, The University of Queensland, Brisbane, Queensland, Australia  \n2School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Queensland, Australia  \n3School of Public Health, The University of Sydney, Sydney, New South Wales, Australia  \n4Department of Palliative and Supportive Care Mater Health Services, Mater Research-University of Queensland, South Brisbane, Queensland, Australia 5Department of Palliative Care, St. Vincent's Private Hospital Brisbane, Brisbane, Queensland, Australia  \nCorrespondence  \nRebecca E. Olson.  \nEmail: [r.olson@uq.edu.au](r.olson@uq.edu.au)  \nFunding information  \nMater Clinical Research Seeding Grant, Grant/Award Number: 2017-2019; National Health and Medical Research Council, Grant/Award Number:  \nAPP1140160  \nAbstract  \nExperiences of advanced cancer are assembled and (re)positioned with reference to illness, symptoms and maintaining ‘wellbeing’. Medical cannabis is situated at a borderline in this and the broader social domain:  \nbetween stigmatised and normalised; recreational and pharmaceutical; between perception, experience, discourse and scientific proof of benefit. Yet, in the hyper-medicalised context of randomised clinical trials (RCTs), cancer, wellbeing and medical cannabis are narrowly assessed using individualistic numerical scores. This article attends to patients’ perceptions and experiences at this borderline, presenting novel findings from a sociological sub-study embedded within RCTs focused on the use of medical cannabis for symptom relief in advanced cancer. Through a Deleuzo–Guattarian-informed framework, we highlight the fragmentation and reassembling of bodies and propose body-situated experiences of wellbeing in the realm of advanced cancer. Problematising ‘biopsychosocial’ approaches that centre an individualised disconnected patient body in understandings of wellbeing, experiences of cancer  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2023 The Authors. Sociology of Health & Illness published by John Wiley & Sons Ltd on behalf of Foundation for the Sociology of Health & Illness.  \nSociol Health Illn. 2023;45:1709–[1729.](1729. wileyonlinelibrary.com/journal/shil)[ wileyonlinelibrary.com/journal/shil](1729. wileyonlinelibrary.com/journal/shil)  1709  \nand potential treatments, our findings foreground relational affect and embodied experience, and the role of desire in understanding what wellbeing is and can be. This also underpins and enables exploration of the affective reassembling ascribed to medical cannabis, with particular focus on how it is positioned within RCTs.  \nKEYW ORDS  \nAustralia, cancer, Deleuze and Guattari, medicinal cannabis, palliative care, wellbeing  \nINTRODUCTION  \nCancer disrupts wellness. Diagnosis, disease and associated symptoms can unsettle a person’s physical, psychological and social functioning (Ranchoret al., 2010; Reeve et al., 2010). Commonly used clinical measures of ‘quality of life’ reflect such losses, drawing on tools that translate wellbeing into biopsychosocial functioning (Hui & Bruera, 2016) . Medical cannabis (MC) is one option for alleviating effects of cancer and anti-cancer treatments, potentially disrupting symptoms and the experience of disease. Situated bodies that are often deemed problematic intersect the disruptive experiences of both cancer and cannabis.  \nA Deleuzo–Guattarian account of bodies and assemblages, however, has the potential to (re) focus our attention on what bodies can do. Shifting beyond a compartmentalised body/mind/ society ","cbCaic9cOzYVvxTY","https://ap.wps.com/l/cbCaic9cOzYVvxTY","pdf",265629,21,"English","# Abstract\n# Introduction\n## Cancer disrupts wellness and quality of life measures\n## Medical cannabis and embodied experiences\n# Wellbeing in the clinic: Cancer, pain and measuring quality of life\n## Cancer pain prevalence and impacts\n## Pain perceptions, identity, and future expectations","[{\"question\":\"How does the article critique conventional quality-of-life measurement in advanced cancer trials?\",\"answer\":\"It argues that in RCT settings, quality of life, wellbeing, and medical cannabis benefits are narrowly assessed through individualistic numerical scores, which limits how patients’ lived experiences are captured.\"},{\"question\":\"What social boundaries does the article highlight for medicinal cannabis?\",\"answer\":\"It situates medical cannabis at a borderline between stigmatised and normalised use, and between recreational and pharmaceutical frames, linking discourse, experience, and perceived scientific proof of benefit.\"},{\"question\":\"How does the study explore wellbeing among advanced cancer patients?\",\"answer\":\"It presents novel findings from a sociological sub-study embedded within RCTs, focusing on patients’ perceptions and embodied, relational experiences of wellbeing, including how desire and body reassembly shape what wellbeing means.\"}]","Quality of life beyond measure - Advanced cancer patients, wellbeing and medicinal cannabis | PDF",1790566075,53]